Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1979 1
1988 1
2007 2
2009 1
2010 1
2011 2
2012 2
2014 7
2015 3
2016 3
2017 1
2018 1
2019 3
2020 2
2021 6
2022 4
2023 5
2024 3

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

42 results

Results by year

Filters applied: . Clear all
Page 1
Ustekinumab safety and effectiveness in patients with ulcerative colitis: results from a large real-life study.
Tursi A, Mocci G, Scaldaferri F, Napolitano D, Maresca R, Pugliese D, Semprucci G, Savarino E, Cuomo A, Donnarumma L, Bodini G, Pasta A, Maconi G, Cataletti G, Pranzo G, Rodinò S, Sebkova L, Costa F, Ferronato A, Gaiani F, Marzo M, Luppino I, Fabiano G, Paese P, Elisei W, Monterubbianesi R, Faggiani R, Grossi L, Serio M, Scarcelli A, Lorenzetti R, Allegretta L, Chiri S, Grasso G, Antonelli E, Bassotti G, Spagnuolo R, Luzza F, Fanigliulo L, Rocco G, Sacchi C, Zampaletta C, Rocchi C, Bolognini L, Bendia E, Bianco MA, Capone P, Meucci C, Colucci R, Tonti P, Neve V, Della Valle N, Felice C, Pica R, Cocco A, Forti G, Onidi FM, Usai Satta P, Checchin D, Gravina AG, Pellegrino R, Picchio M, Papa A. Tursi A, et al. Among authors: faggiani r. Expert Opin Biol Ther. 2024 Jan-Feb;24(1-2):101-109. doi: 10.1080/14712598.2024.2309300. Epub 2024 Jan 25. Expert Opin Biol Ther. 2024. PMID: 38250818
Diverticular Inflammation and Complication Assessment classification, CODA score and fecal calprotectin in clinical assessment of patients with diverticular disease: A decision curve analysis.
Tursi A, Piovani D, Brandimarte G, Di Mario F, Elisei W, Picchio M, Allegretta L, Annunziata ML, Bafutto M, Bassotti G, Bianco MA, Colucci R, Conigliaro R, Dumitrascu DL, Escalante R, Ferrini L, Forti G, Franceschi M, Graziani MG, Lammert F, Latella G, Maconi G, Compare D, Nardone G, Camara De Castro Oliveira L, Oliveira EC, Papa A, Papagrigoriadis S, Pietrzak A, Pontone S, Poskus T, Pranzo G, Reichert MC, Rodinò S, Regula J, Scaccianoce G, Scaldaferri F, Vassallo R, Zampaletta C, Zullo A, Spaziani E, Bonovas S, Danese S; DICA International Group. Tursi A, et al. United European Gastroenterol J. 2023 Sep;11(7):642-653. doi: 10.1002/ueg2.12369. Epub 2023 Aug 7. United European Gastroenterol J. 2023. PMID: 37550901 Free PMC article.
Letter: diverticulosis in inflammatory bowel diseases.
Tursi A, Elisei W, Picchio M, Forti G, Giorgetti G, Faggiani R, Zampaletta C, Brandimarte G. Tursi A, et al. Among authors: faggiani r. Aliment Pharmacol Ther. 2014 Apr;39(8):899-900. doi: 10.1111/apt.12656. Aliment Pharmacol Ther. 2014. PMID: 24635315 Free article. No abstract available.
Use of tofacitinib as first or second-line therapy is associated with better outcomes in patients with ulcerative colitis: data from a real-world study.
Tursi A, Mocci G, Cingolani L, Savarino E, Pica R, Cocco A, Zippi M, Napolitano D, Schiavoni E, Pugliese D, Scaldaferri F, Costa F, Marzo M, Serio M, Scarcelli A, Bolognini L, Bendia E, Maconi G, Cannatelli R, Piergallini S, Bodini G, Calabrese F, Ferronato A, Pranzo G, Elisei W, Monterubbianesi R, Faggiani R, Rodinò S, Sebkova L, Grossi L, Gaiani F, Dè Angelis G, Lorenzetti R, Allegretta L, Cazzato AI, Scorza S, Della Valle N, Sacco R, Forti G, Colucci R, Tonti P, Neve V, Rocco G, Sacchi C, Zampaletta C, Pagnini C, Graziani MG, Di Paolo MC, Onidi FM, Usai Satta P, Picchio M, Papa A. Tursi A, et al. Among authors: faggiani r. Expert Opin Pharmacother. 2023 Sep-Dec;24(14):1649-1656. doi: 10.1080/14656566.2023.2230126. Epub 2023 Jun 28. Expert Opin Pharmacother. 2023. PMID: 37358928
Transcriptome profile of human colorectal adenomas.
Sabates-Bellver J, Van der Flier LG, de Palo M, Cattaneo E, Maake C, Rehrauer H, Laczko E, Kurowski MA, Bujnicki JM, Menigatti M, Luz J, Ranalli TV, Gomes V, Pastorelli A, Faggiani R, Anti M, Jiricny J, Clevers H, Marra G. Sabates-Bellver J, et al. Among authors: faggiani r. Mol Cancer Res. 2007 Dec;5(12):1263-75. doi: 10.1158/1541-7786.MCR-07-0267. Mol Cancer Res. 2007. PMID: 18171984
Effectiveness of ustekinumab in patients with refractory Crohn's disease: a multicentre real-life study in Italy.
Scribano ML, Aratari A, Neri B, Bezzio C, Balestrieri P, Baccolini V, Falasco G, Camastra C, Pantanella P, Monterubbianesi R, Tullio A, Saibeni S, Papi C, Biancone L, Cosintino R, Faggiani R. Scribano ML, et al. Among authors: faggiani r. Therap Adv Gastroenterol. 2022 Feb 14;15:17562848211072412. doi: 10.1177/17562848211072412. eCollection 2022. Therap Adv Gastroenterol. 2022. PMID: 35186121 Free PMC article.
Light emission in nanogaps: overcoming quenching.
Yang J , Faggiani R , Lalanne P . Yang J , et al. Among authors: faggiani r. Nanoscale Horiz. 2016 Jan 18;1(1):11-13. doi: 10.1039/c5nh00059a. Epub 2015 Nov 13. Nanoscale Horiz. 2016. PMID: 32260597
42 results